11:37 am, Wednesday, 22 October 2025

GSK pledges $30 billion U.S. investment in R&D and factories

Sarakhon Report

Major life-sciences push tied to state visits

GlaxoSmithKline said it will invest $30 billion in U.S. research, development and manufacturing over five years, including a new Pennsylvania factory for cancer and respiratory drugs. The package was announced alongside high-level diplomatic visits highlighting industrial ties.

Jobs and supply-chain goals highlighted

GSK said the investment will boost domestic drug production and create thousands of jobs while strengthening transatlantic R&D links. Analysts said the move signals renewed focus on onshore manufacturing for strategic medicines.

06:43:29 pm, Wednesday, 17 September 2025

GSK pledges $30 billion U.S. investment in R&D and factories

06:43:29 pm, Wednesday, 17 September 2025

Major life-sciences push tied to state visits

GlaxoSmithKline said it will invest $30 billion in U.S. research, development and manufacturing over five years, including a new Pennsylvania factory for cancer and respiratory drugs. The package was announced alongside high-level diplomatic visits highlighting industrial ties.

Jobs and supply-chain goals highlighted

GSK said the investment will boost domestic drug production and create thousands of jobs while strengthening transatlantic R&D links. Analysts said the move signals renewed focus on onshore manufacturing for strategic medicines.